Larvol Delta - Inhibikase-Therapeutics-Reports-Full-Year-2021-Financial-Results-and-Highlights-Recent-Period-Activity

IkT-148009 - Inhibikase, Clintrex

https://www.prnewswire.com/news-releases/inhibikase-therapeutics-reports-full-year-2021-financial-results-and-highlights-recent-period-activity-301515340.html

Mar 31, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next